
ESSA Pharma (EPIX) Stock Forecast & Price Target
ESSA Pharma (EPIX) Analyst Ratings
Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%
ESSA Pharma (EPIX) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of ESSA Pharma and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of ESSA Pharma and is not a guaranteed prediction by Public.com or investment advice.
ESSA Pharma (EPIX) Analyst Forecast & Price Prediction
Get the latest ESSA Pharma (EPIX) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in ESSA Pharma (EPIX)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About ESSA Pharma (EPIX) Forecast
Analysts have given ESSA Pharma (EPIX) a Buy based on their latest research and market trends.
According to 3 analysts, ESSA Pharma (EPIX) has a Buy consensus rating as of Jul 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.